Loading clinical trials...
Loading clinical trials...
The aim of this trial is to study the efavirenz-rifabutin interaction. Thus, this trial will enroll patients with HIV and tuberculosis co-infections who are receiving a rifabutin-based regimen and who...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centers for Disease Control and Prevention
Collaborators
NCT04923958 · Tuberculosis
NCT06590428 · Rifampin-resistant Tuberculosis, Drug-resistant Tuberculosis
NCT06694805 · HIV Infections
NCT06627764 · Substance Abuse, Intimate Partner Violence (IPV), and more
NCT06192160 · Pulmonary Tuberculosis
Central Arkansas Veterans Health System
Little Rock, Arkansas
LA County/USC Medical Center
Los Angeles, California
University of California, San Francisco
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions